Ocular Therapeutix Analyst Ratings and Price Targets | NASDAQ:OCUL

Comments

Ocular Therapeutix Inc Analyst Ratings

OCULNASDAQ

Trade with Public

$8.88

-0.18-1.99%

At close: Feb 12, 4:00 PM EST

$6.00

-3.06-33.77%

Pre-Market: 7:17 AM EST

Overview News Earnings Options GuidanceAnalyst RatingsInsider Trades Short Interest Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$31.00

Lowest Price Target¹

$15.00

Consensus Price Target¹

$21.00

Ocular Therapeutix Analyst Ratings and Price Targets | NASDAQ:OCUL | Benzinga

Ocular Therapeutix Inc has a consensus price target of $21 based on the ratings of 13 analysts. The high is $31 issued by Piper Sandler on October 3, 2025. The low is $15 issued by Piper Sandler on June 14, 2024. The 3 most-recent analyst ratings were released by Chardan Capital, Needham, and HC Wainwright & Co. on December 9, 2025, December 8, 2025, and December 8, 2025, respectively. With an average price target of $20.67 between Chardan Capital, Needham, and HC Wainwright & Co., there's an implied 262.57% upside for Ocular Therapeutix Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Sep 25

Oct 25

Nov 25

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Chardan Capital

Needham

HC Wainwright & Co.

TD Cowen

Piper Sandler

¹calculated from analyst ratings

Analyst Ratings for Ocular Therapeutix

	Buy Now						Get Alert
12/09/2025	Buy Now	268.42%	Chardan Capital	$21 → $21	Maintains	Buy	Get Alert
12/08/2025	Buy Now	250.88%	Needham	$20 → $20	Reiterates	Buy → Buy	Get Alert
12/08/2025	Buy Now	268.42%	HC Wainwright & Co.	$19 → $21	Maintains	Buy	Get Alert
11/25/2025	Buy Now	233.33%	HC Wainwright & Co.	$19 → $19	Reiterates	Buy → Buy	Get Alert
11/05/2025	Buy Now	268.42%	Chardan Capital	$21 → $21	Maintains	Buy	Get Alert
10/30/2025	Buy Now	250.88%	TD Cowen	$14 → $20	Maintains	Buy	Get Alert
10/08/2025	Buy Now	233.33%	HC Wainwright & Co.	$15 → $19	Maintains	Buy	Get Alert
10/03/2025	Buy Now	443.86%	Piper Sandler	$21 → $31	Maintains	Overweight	Get Alert
10/03/2025	Buy Now	321.05%	Baird	$17 → $24	Maintains	Outperform	Get Alert
10/02/2025	Buy Now	268.42%	Chardan Capital	$21 → $21	Maintains	Buy	Get Alert
10/01/2025	Buy Now	250.88%	Needham	$15 → $20	Maintains	Buy	Get Alert
10/01/2025	Buy Now	408.77%	JMP Securities	$20 → $29	Maintains	Market Outperform	Get Alert
09/15/2025	Buy Now	268.42%	Chardan Capital	→ $21	Initiates	→ Buy	Get Alert
08/06/2025	Buy Now	250.88%	Scotiabank	$22 → $20	Maintains	Sector Outperform	Get Alert
08/05/2025	Buy Now	163.16%	Needham	$14 → $15	Maintains	Buy	Get Alert
05/29/2025	Buy Now	163.16%	HC Wainwright & Co.	$15 → $15	Reiterates	Buy → Buy	Get Alert
05/06/2025	Buy Now	145.61%	Needham	$15 → $14	Maintains	Buy	Get Alert
04/08/2025	Buy Now	—	William Blair	—	Initiates	→ Outperform	Get Alert
04/08/2025	Buy Now	163.16%	Needham	$15 → $15	Reiterates	Buy → Buy	Get Alert
03/18/2025	Buy Now	198.25%	RBC Capital	→ $17	Initiates	→ Outperform	Get Alert
03/11/2025	Buy Now	163.16%	Needham	→ $15	Initiates	→ Buy	Get Alert
03/04/2025	Buy Now	233.33%	Citizens Capital Markets	$22 → $19	Maintains	Market Outperform	Get Alert
03/04/2025	Buy Now	163.16%	HC Wainwright & Co.	$15 → $15	Reiterates	Buy → Buy	Get Alert
12/03/2024	Buy Now	163.16%	HC Wainwright & Co.	$15 → $15	Reiterates	Buy → Buy	Get Alert
11/15/2024	Buy Now	163.16%	HC Wainwright & Co.	$14 → $15	Maintains	Buy	Get Alert
10/16/2024	Buy Now	285.96%	Scotiabank	→ $22	Initiates	→ Sector Outperform	Get Alert
10/16/2024	Buy Now	145.61%	HC Wainwright & Co.	$14 → $14	Reiterates	Buy → Buy	Get Alert
08/08/2024	Buy Now	198.25%	Baird	$18 → $17	Maintains	Outperform	Get Alert
08/01/2024	Buy Now	145.61%	HC Wainwright & Co.	$14 → $14	Reiterates	Buy → Buy	Get Alert
06/21/2024	Buy Now	163.16%	Piper Sandler	$15 → $15	Maintains	Overweight	Get Alert
06/20/2024	Buy Now	92.98%	TD Cowen	$7 → $11	Upgrade	Hold → Buy	Get Alert
06/14/2024	Buy Now	163.16%	Piper Sandler	$15 → $15	Maintains	Overweight	Get Alert
06/14/2024	Buy Now	145.61%	HC Wainwright & Co.	$14 → $14	Reiterates	Buy → Buy	Get Alert
05/08/2024	Buy Now	145.61%	HC Wainwright & Co.	$16 → $14	Maintains	Buy	Get Alert
05/08/2024	Buy Now	285.96%	JMP Securities	$24 → $22	Maintains	Market Outperform	Get Alert
05/08/2024	Buy Now	22.81%	TD Cowen	$11 → $7	Maintains	Hold	Get Alert
04/19/2024	Buy Now	180.7%	HC Wainwright & Co.	$16 → $16	Reiterates	Buy → Buy	Get Alert
04/16/2024	Buy Now	321.05%	JMP Securities	$24 → $24	Reiterates	Market Outperform → Market Outperform	Get Alert
03/13/2024	Buy Now	321.05%	JMP Securities	$24 → $24	Reiterates	Market Outperform → Market Outperform	Get Alert
03/13/2024	Buy Now	163.16%	HC Wainwright & Co.	$12 → $15	Maintains	Buy	Get Alert
03/12/2024	Buy Now	92.98%	TD Cowen	$8 → $11	Maintains	Market Perform	Get Alert
03/12/2024	Buy Now	321.05%	JMP Securities	$12 → $24	Maintains	Market Outperform	Get Alert
02/26/2024	Buy Now	163.16%	Piper Sandler	$10 → $15	Maintains	Overweight	Get Alert
02/14/2024	Buy Now	110.53%	HC Wainwright & Co.	$12 → $12	Reiterates	Buy → Buy	Get Alert
02/09/2024	Buy Now	163.16%	B of A Securities	→ $15	Initiates	→ Buy	Get Alert
10/04/2023	Buy Now	110.53%	HC Wainwright & Co.	→ $12	Reiterates	Buy → Buy	Get Alert
09/14/2023	Buy Now	215.79%	Baird	→ $18	Reiterates	Outperform → Outperform	Get Alert
08/08/2023	Buy Now	110.53%	HC Wainwright & Co.	→ $12	Reiterates	Buy → Buy	Get Alert
06/13/2023	Buy Now	110.53%	Baird	$10 → $12	Maintains	Outperform	Get Alert
06/13/2023	Buy Now	110.53%	JMP Securities	→ $12	Reiterates	→ Market Outperform	Get Alert
06/13/2023	Buy Now	110.53%	HC Wainwright & Co.	$10 → $12	Maintains	Buy	Get Alert
06/08/2023	Buy Now	75.44%	HC Wainwright & Co.	→ $10	Reiterates	Buy → Buy	Get Alert
05/09/2023	Buy Now	75.44%	HC Wainwright & Co.	$11 → $10	Maintains	Buy	Get Alert
05/09/2023	Buy Now	110.53%	JMP Securities	$11 → $12	Maintains	Outperform	Get Alert
04/21/2023	Buy Now	215.79%	Baird	→ $18	Initiates	→ Outperform	Get Alert
03/07/2023	Buy Now	92.98%	HC Wainwright & Co.	→ $11	Reiterates	→ Buy	Get Alert
03/07/2023	Buy Now	92.98%	JMP Securities	$12 → $11	Maintains	Market Outperform	Get Alert

FAQ

What is the target price for Ocular Therapeutix (OCUL) stock?

The latest price target for Ocular Therapeutix (NASDAQ:OCUL) was reported by Chardan Capital on December 9, 2025. The analyst firm set a price target for $21.00 expecting OCUL to rise to within 12 months (a possible 250.00% upside). 23 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Ocular Therapeutix (OCUL)?

The latest analyst rating for Ocular Therapeutix (NASDAQ:OCUL) was provided by Chardan Capital, and Ocular Therapeutix maintained their buy rating.

When was the last upgrade for Ocular Therapeutix (OCUL)?

The last upgrade for Ocular Therapeutix Inc happened on June 20, 2024 when TD Cowen raised their price target to $11. TD Cowen previously had a hold for Ocular Therapeutix Inc.

When was the last downgrade for Ocular Therapeutix (OCUL)?

There is no last downgrade for Ocular Therapeutix.

When is the next analyst rating going to be posted or updated for Ocular Therapeutix (OCUL)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocular Therapeutix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocular Therapeutix was filed on December 9, 2025 so you should expect the next rating to be made available sometime around December 9, 2026.

Is the Analyst Rating Ocular Therapeutix (OCUL) correct?

While ratings are subjective and will change, the latest Ocular Therapeutix (OCUL) rating was a maintained with a price target of $21.00 to $21.00. The current price Ocular Therapeutix (OCUL) is trading at is $6.00, which is out of the analyst’s predicted range.